Number of suitable people: CDEC mentioned the uncertainty in the amount of patients with reasonably intense to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some individuals who are categorised as getting mild or reasonable condition might have a severe bleeding phenotype, https://hemgenix42715.imblogs.net/85649661/everything-about-hemgenix